Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-01
1995-12-05
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
054729599
ABSTRACT:
The invention relates to compounds of the formula ##STR1## wherein B.sub.1 and B.sub.2 are each independently hydrogen; hydroxy; --OR.sub.2 wherein R.sub.2 is a C.sub.1 -C.sub.4 alkyl or an Ar--Y group wherein Ar is aryl and Y is a hydrogen or C.sub.1 -C.sub.4 alkyl; or, where B.sub.1 and B.sub.2 are attached to adjacent carbon atoms, B.sub.1 and B.sub.2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy;
A is a bond, methylene or oxygen, sulfur, NR.sub.4 or NCOR.sub.5 wherein R.sub.4 is hydrogen, a C.sub.1 -C.sub.4 alkyl or an Ar--Y-- group and R.sub.5 is --CF.sub.3, a C.sub.1 -C.sub.10 alkyl or an Ar--Y-- group; R.sub.3 is hydrogen or --CH.sub.2 OC(O)C(CH.sub.3).sub.3 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl or --CH.sub.2 OC(O)--C(CH.sub.3).sub.3 ; and n is an integer 1 to 3,
that are useful as inhibitors of enkephalinase and ACE.
REFERENCES:
patent: 3334091 (1967-07-01), Houlihan
patent: 3334095 (1967-08-01), Houluhan
patent: 4080449 (1978-03-01), Croisier et al.
patent: 4320057 (1982-03-01), Freed et al.
patent: 4391752 (1983-07-01), Crossley
patent: 4415496 (1983-11-01), Harris et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4584294 (1986-04-01), Ruyle
patent: 4658024 (1987-04-01), Attwood et al.
patent: 4772701 (1988-09-01), Attwood et al.
patent: 4808713 (1989-02-01), Attwood et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4973585 (1990-11-01), Flynn et al.
patent: 4999370 (1991-03-01), Ruger et al.
patent: 5043346 (1991-07-01), Hock et al.
patent: 5208230 (1993-05-01), Flynn et al.
patent: 5238932 (1994-07-01), Flynn et al.
J. Med. Chem. 1992, 35, 823-832, Timothy D. Ocain et al.
Bioorganic and Medical Chem. Letters vol. 1, 309, 1991.
Flynn, et al., J. Am. Chem. Soc. 109, 7914 (1987).
Flynn, et al., Peptide Chemistry (1987); T. Shiba & Sakakibara (ed.), Protein Research Foundation, Osaka (1988), 631-636.
Flynn, et al., Tetrahedron Letters, vol. 31 (6), 815-818 (1990).
Attwood, et al., J. Chem. Soc. Perkin Trans, I, pp. 1011-1019 (1986).
Natoff, et al., Drugs of the Future, Vol 12 (5): 475-483 (1987).
Journal of Am. Coll. of Card. vol. 17, No. 6, pp. 137B-142B (May 1991).
Supplement I Cir. vol. 86(4) P. 1-220(0873) (Oct. 1992).
Flynn Gary A.
Warshawsky Alan M.
Barney Charlotte L.
Henley III Raymond
Merrell Dow Pharmaceuticals Inc.
Spivack Phyllis G.
LandOfFree
Carboxyalkyl derivatives useful as inhibitors of enkephalinase a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxyalkyl derivatives useful as inhibitors of enkephalinase a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkyl derivatives useful as inhibitors of enkephalinase a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374279